In Brief: Alpharma
This article was originally published in The Tan Sheet
Executive Summary
Alpharma: Gert Wilhelm Munthe is new president and chief operating officer of the private label manufacturer. Munthe, formerly president and CEO of Oslo, Norway-based NetCom ASA, has been a member of the Alpharma board for four years. He reports to Alpharma Chairman and CEO Einar Sissener and is expected to succeed Sissener when he steps down from the CEO position in 1999; Sissener will continue as chairman of the board. The company's five Strategic Business Unit presidents, as well as the chief financial officer, now report to Munthe. Alpharma recently received tentative FDA approval for its ANDA for ibuprofen oral suspension, comparable to McNeil's Children's Motrin, for which marketing exclusivity expires June 16 ("The Tan Sheet" Jan. 19, In Brief)...